RESEARCH PAPERS: Papers on Tissue Engineering

Transplantation of Polymer Encapsulated Neurotransmitter Secreting Cells: Effect of the Encapsulation Technique

[+] Author and Article Information
P. Aebischer, S. R. Winn, P. A. Tresco

Section of Artificial Organs, Biomaterials and Cellular Technology, Brown University, Providence, RI

C. B. Jaeger

Center for Paralysis Research, Purdue University, West Lafayette, IN

L. A. Greene

Department of Pathology and Center for Neurobiology and Behavior, Columbia University, New York, NY

J Biomech Eng 113(2), 178-183 (May 01, 1991) (6 pages) doi:10.1115/1.2891231 History: Received January 20, 1991; Revised February 01, 1991; Online March 17, 2008


Deficits associated with neurological diseases may be improved by the transplantation within the brain lesioned target structure of polymer encapsulated cells releasing the missing neurotransmitter. Surrounding cells with a permselective membrane of appropriate molecular weight cut-off allows inward diffusion of nutrients and outward diffusion of neurotransmitters, but prevents immunoglobulins or immune cells from reaching the transplant. This technique therefore allows transplantation of postmitotic cells across species. It also permits neural grafting of transformed cell lines since the polymer capsule prevents the formation of tumors by physically sequestering the transplanted tissue. In the present study, we compared the ability of dopaminesecreting cells, encapsulated by 2 different methods, to reverse experimental Parkinson’s disease, a neurodegenerative disease characterized by motor disturbances due to a lack of dopamine within the striatum following degeneration of the dopaminergic nigro-striatal pathway. PC12 cells were loaded in polyelectrolyte-based microcapsules or thermoplastic-based macrocapsules and maintained in vitro or transplanted in a rat experimental Parkinson model for 4 weeks. Chemically-induced depolarization increased the in vitro release of dopamine from macrocapsules over time, while no increase in release was observed from microcapsules. Encapsulated PC12 cells were able to reduce lesion-induced rotational asymmetry in rats for at least 4 weeks, regardless of the encapsulation technique used. With both encapsulation methods, PC12 cell viability was greater in vivo than in vitro which suggests that the striatum releases trophic factors for PC12 cells. More brain tissue damage was observed with microcapsules than macrocapsules, possibly the result of the difficulty of manipulating the more fragile microcapsules. Material resembling alginate was observed in the brain parenchyma surrounding the microcapsules, whereas no structural changes were observed with poly (acrylonitrile vinyl chloride) based capsules 4 weeks post-implantation. This fact raises questions about the in vivo stability of polyelectrolyte-based capsules implanted in the nervous system. We conclude that the implantation of polymer-encapsulated cells may provide a means for long-term delivery of neurotransmitters providing adequate encapsulation technology.

Copyright © 1991 by The American Society of Mechanical Engineers
Your Session has timed out. Please sign back in to continue.





Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging and repositioning the boxes below.

Related Journal Articles
Related eBook Content
Topic Collections

Sorry! You do not have access to this content. For assistance or to subscribe, please contact us:

  • TELEPHONE: 1-800-843-2763 (Toll-free in the USA)
  • EMAIL: asmedigitalcollection@asme.org
Sign In